Ind-Enabling-Studies on Bioeconhttps://en.bioecon.ru/technologies/ind-enabling-studies/Recent content in Ind-Enabling-Studies on BioeconHugoen-USSat, 04 Jul 2026 12:42:08 +0700Corporate biotech accelerators (JLABS, Bayer CoLaborator)https://en.bioecon.ru/technology/corporate-biotech-accelerators/Sat, 04 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/corporate-biotech-accelerators/Pharma-sponsored accelerators and shared wet-lab hubs — JLABS, Bayer Co.Lab/G4A, Boehringer Ingelheim’s BI X programs — that give startups equity-free or seed-funded access to lab infrastructure and IND-track mentorship in exchange for first-look licensing or M&A rights.